Merck eyeing devices?
This article was originally published in The Gray Sheet
Executive Summary
During the pharma giant's Dec. 15 annual business briefing in Whitehouse Station, N.J., CEO Dick Clark suggests that Merck will "pursue certain acquisitions in diagnostics and devices, not to build a stand alone business in that area, but rather to enhance our core business"...